- Home
- OPAD vs ANTX Comparison
OPAD vs ANTX Comparison
Compare OPAD & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- ANTX
- Stock Information
- Founded
- OPAD 2015
- ANTX 2017
- Country
- OPAD United States
- ANTX United States
- Employees
- OPAD N/A
- ANTX N/A
- Industry
- OPAD Real Estate
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- OPAD Finance
- ANTX Health Care
- Exchange
- OPAD Nasdaq
- ANTX Nasdaq
- Market Cap
- OPAD 25.3M
- ANTX 33.2M
- IPO Year
- OPAD N/A
- ANTX 2022
- Fundamental
- Price
- OPAD $1.31
- ANTX $1.06
- Analyst Decision
- OPAD Hold
- ANTX Buy
- Analyst Count
- OPAD 5
- ANTX 2
- Target Price
- OPAD $2.38
- ANTX $2.00
- AVG Volume (30 Days)
- OPAD 128.8K
- ANTX 283.5K
- Earning Date
- OPAD 08-04-2025
- ANTX 08-12-2025
- Dividend Yield
- OPAD N/A
- ANTX N/A
- EPS Growth
- OPAD N/A
- ANTX N/A
- EPS
- OPAD N/A
- ANTX N/A
- Revenue
- OPAD $794,159,000.00
- ANTX N/A
- Revenue This Year
- OPAD N/A
- ANTX N/A
- Revenue Next Year
- OPAD $40.79
- ANTX N/A
- P/E Ratio
- OPAD N/A
- ANTX N/A
- Revenue Growth
- OPAD N/A
- ANTX N/A
- 52 Week Low
- OPAD $0.91
- ANTX $0.87
- 52 Week High
- OPAD $5.13
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- OPAD 67.20
- ANTX 43.41
- Support Level
- OPAD $0.91
- ANTX $1.07
- Resistance Level
- OPAD $1.14
- ANTX $1.11
- Average True Range (ATR)
- OPAD 0.12
- ANTX 0.05
- MACD
- OPAD 0.05
- ANTX 0.00
- Stochastic Oscillator
- OPAD 63.49
- ANTX 7.14
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.